Grace Therapeutics, Stock Fundamentals
| GRCE Stock | 3.36 0.01 0.30% |
Grace Therapeutics, fundamentals help investors to digest information that contributes to Grace Therapeutics,'s financial success or failures. It also enables traders to predict the movement of Grace Stock. The fundamental analysis module provides a way to measure Grace Therapeutics,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Grace Therapeutics, stock.
At present, Grace Therapeutics,'s Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Research Development is expected to grow to about 6.7 M, whereas Selling General Administrative is forecasted to decline to about 6.3 M. Grace | Select Account or Indicator |
Grace Therapeutics, Company Cash Flow From Operations Analysis
Grace Therapeutics,'s Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Grace Therapeutics, Cash Flow From Operations | (12.33 M) |
Most of Grace Therapeutics,'s fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Grace Therapeutics, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
In accordance with the recently published financial statements, Grace Therapeutics, has (12.33 Million) in Cash Flow From Operations. This is 102.34% lower than that of the Healthcare sector and 119.72% lower than that of the Biotechnology industry. The cash flow from operations for all United States stocks is 101.27% higher than that of the company.
Grace Therapeutics, Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Grace Therapeutics,'s current stock value. Our valuation model uses many indicators to compare Grace Therapeutics, value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Grace Therapeutics, competition to find correlations between indicators driving Grace Therapeutics,'s intrinsic value. More Info.Grace Therapeutics, is one of the top stocks in net income category among its peers. It also is rated as one of the top companies in total debt category among its peers . At present, Grace Therapeutics,'s Net Loss is projected to increase significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Grace Therapeutics, by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Grace Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Grace Therapeutics,'s direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Grace Therapeutics, could also be used in its relative valuation, which is a method of valuing Grace Therapeutics, by comparing valuation metrics of similar companies.Grace Therapeutics, is currently under evaluation in cash flow from operations category among its peers.
Grace Fundamentals
| Net Income | (12.85 M) | ||||
| Total Debt | 11.56 M | ||||
| Cash Flow From Operations | (12.33 M) | ||||
| Total Asset | 73.3 M | ||||
| Retained Earnings | (211.12 M) | ||||
| Working Capital | 22.33 M | ||||
| Net Asset | 73.3 M |
About Grace Therapeutics, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Grace Therapeutics,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Grace Therapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Grace Therapeutics, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Grace Therapeutics, is a strong investment it is important to analyze Grace Therapeutics,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Grace Therapeutics,'s future performance. For an informed investment choice regarding Grace Stock, refer to the following important reports:Check out Grace Therapeutics, Piotroski F Score and Grace Therapeutics, Altman Z Score analysis. For information on how to trade Grace Stock refer to our How to Trade Grace Stock guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Grace Therapeutics,. If investors know Grace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Grace Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Grace Therapeutics, is measured differently than its book value, which is the value of Grace that is recorded on the company's balance sheet. Investors also form their own opinion of Grace Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Grace Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Grace Therapeutics,'s market value can be influenced by many factors that don't directly affect Grace Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Grace Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Grace Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Grace Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.